Progress in Stem Cell Therapy for Major Human Neurological Disorders

被引:0
作者
P. L. Martínez-Morales
A. Revilla
I. Ocaña
C. González
P. Sainz
D. McGuire
I. Liste
机构
[1] Instituto de Salud Carlos III (ISCIII),Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas
来源
Stem Cell Reviews and Reports | 2013年 / 9卷
关键词
Stem cells; Neurodegeneration; Cell therapy; Neurogenesis; Alzheimer’s disease; Stroke;
D O I
暂无
中图分类号
学科分类号
摘要
Human neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease, stroke or spinal cord injury are caused by the loss of neurons and glial cells in the brain or spinal cord in the Central Nervous System (CNS). Stem cell technology has become an attractive option to investigate and treat these diseases. Several types of neurons and glial cells have successfully been generated from stem cells, which in some cases, have ameliorated some dysfunctions both in animal models of neurological disorders and in patients at clinical level. Stem cell-based therapies can be beneficial by acting through several mechanisms such as cell replacement, modulation of inflammation and trophic actions. Here we review recent and current remarkable clinical studies involving stem cell-based therapy for AD and stroke and provide an overview of the different types of stem cells available nowadays, their main properties and how they are developing as a possible therapy for neurological disorders.
引用
收藏
页码:685 / 699
页数:14
相关论文
共 539 条
[1]  
Lindvall O(2010)Stem cells in human neurodegenerative disorders–time for clinical translation? Journal of Clinical Investigation 120 29-40
[2]  
Kokaia Z(2011)Stem cell technology for neurodegenerative diseases Annals of Neurology 70 353-361
[3]  
Lunn JS(2003)Alzheimer’s disease and Parkinson’s disease The New England Journal of Medicine 348 1356-1364
[4]  
Sakowski SA(2012)Alzheimer mechanisms and therapeutic strategies Cell 148 1204-1222
[5]  
Hur J(2011)Patient-specific pluripotent stem cells in neurological diseases Stem Cells International 2011 212487-1360
[6]  
Feldman EL(2008)Taking stem cells to the clinic: major challenges Journal of Cellular Biochemistry 105 1352-1147
[7]  
Nussbaum RL(1998)Embryonic stem cell lines derived from human blastocysts Science 282 1145-551
[8]  
Ellis CE(2011)Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease Nature 480 547-1364
[9]  
Huang Y(2010)Ca2+ and cAMP signaling in human embryonic stem cell-derived dopamine neurons Stem Cells and Development 19 1355-280
[10]  
Mucke L(2009)Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling Nature Biotechnology 27 275-419